Merck & Co., Inc.
USD129.38
+0.72 (+0.56%)
CEO
Robert Davis
IPO Date
1978-01-13
Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
NYSE
Country
US
Open
$128.15
Prev. Close
$128.66
Day Low
$126.83
Day High
$129.97
52W Low
$76.66
52W High
$129.95
Market Cap
$319.55B
Volume
7.31M
| 14.7 |
| 31 Dec 2023 | FY | 73.2% | 0.6% | 1.0% | 0.3% | 0.97 | 1.25 | 778.7 |
| 31 Dec 2022 | FY | 70.6% | 24.5% | 31.6% | 13.3% | 0.70 | 1.47 | 19.3 |
| 31 Dec 2021 | FY | 72.0% | 26.8% | 34.2% | 12.3% | 0.91 | 1.27 | 14.9 |
| 31 Dec 2020 | FY | 67.2% | 17.0% | 27.9% | 7.7% | 1.32 | 1.02 | 27.9 |
| 31 Dec 2019 | FY | 69.3% | 25.2% | 38.0% | 11.7% | 1.06 | 1.24 | 22.6 |
| 31 Dec 2018 | FY | 68.1% | 14.7% | 23.3% | 7.5% | 0.94 | 1.17 | 30.4 |
| 31 Dec 2017 | FY | 67.8% | 6.0% | 7.0% | 2.7% | 0.71 | 1.33 | 60.4 |
| 31 Dec 2016 | FY | 64.8% | 9.8% | 9.8% | 4.1% | 0.62 | 1.78 | 39.4 |
| 22.0 |
| 30 Sept 2025 | Q3 | 75.6% | 33.7% | 11.2% | 4.5% | 0.80 | 1.66 | 9.0 |
| 30 Jun 2025 | Q2 | 75.7% | 28.0% | 9.0% | 3.8% | 0.72 | 1.42 | 11.2 |
| 31 Mar 2025 | Q1 | 75.1% | 32.5% | 10.5% | 4.4% | 0.72 | 1.41 | 11.1 |
| 31 Dec 2024 | Q4 | 75.5% | 24.0% | 8.1% | 3.2% | 0.83 | 1.36 | 16.9 |
| 30 Sept 2024 | Q3 | 75.5% | 19.0% | 7.1% | 2.7% | 0.86 | 1.36 | 22.9 |
| 30 Jun 2024 | Q2 | 76.8% | 33.9% | 12.5% | 4.8% | 0.87 | 1.47 | 14.9 |
| 31 Mar 2024 | Q1 | 77.6% | 30.2% | 11.8% | 4.5% | 0.85 | 1.25 | 17.4 |
| 31 Dec 2023 | Q4 | 73.3% | -8.4% | -3.3% | -1.1% | 0.97 | 1.25 | -56.8 |